Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effe
- PDF / 738,066 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 35 Downloads / 162 Views
NEPHROLOGY - ORIGINAL PAPER
Tolvaptan treatment in hyponatremia due to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): effects on survival in patients with cancer Irem Bilgetekin1 · Ismail Erturk2 · Fatma Bugdayci Basal1 · Cengiz Karacin1 · Nuri Karadurmus2 · Berna Oksuzoglu1 · Umut Demirci3 Received: 30 May 2020 / Accepted: 24 August 2020 © Springer Nature B.V. 2020
Abstract Purpose To investigate the clinical outcomes of patients with hyponatremia who received supportive treatment or tolvaptan plus supportive treatment and the effects of treatment and other variables on overall survival Methods This study included oncology patients who were hospitalized at two oncology centers between January 1, 2016 and December 31, 2019 for hyponatremia (sodium levels 0.05). In the TpST group, recovery days of the hyponatremia after treatment and the length of hospital stay was shorter and hyponatremia symptoms and hospital complications were less frequent compared to the ST group (p
Data Loading...
